Primary brain targets of nerve agents: The role of the amygdala in comparison to the hippocampus

NeuroToxicology

Volumn 30, Issue 5, 2009, Pages 772-776

  Aroniadou Anderjaska, Vassiliki ^a   Figueiredo, Taiza H ^a   Apland, James P ^b   Qashu, Felicia ^a   Braga, Maria F M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Amygdala; Hippocampus; Nerve agents; Organophosphorus compounds; Seizures; Soman

Indexed keywords

CHOLINESTERASE INHIBITOR; CYCLOSARIN; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; GLUTAMATE RECEPTOR 5; GLUTAMATE RECEPTOR ANTAGONIST; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; NERVE GAS; SARIN; SOMAN; TABUN; UBP 302; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ARTICLE; BEHAVIOR DISORDER; BIOCHEMISTRY; BRAIN DAMAGE; BRAIN REGION; BRAIN SLICE; CHEMICAL WARFARE; COGNITIVE DEFECT; DEATH; ENVIRONMENTAL EXPOSURE; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL; NERVE CELL LESION; NEUROTOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEIZURE;

ACTION POTENTIALS; AMYGDALA; ANIMALS; CHEMICAL WARFARE AGENTS; HIPPOCAMPUS; NEURONS; RATS; SEIZURES; SOMAN;

EID: 70349733007     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.06.011     Document Type: Article

References (70)

1. Akaike K., Tanaka S., HideshiTojo H., Fukumoto S., Imamura S., and Takigawa M. Kainic acid-induced dorsal and ventral hippocampal seizures in rats. Brain Res 900 (2001) 65-71
2. Apland J.P., Aroniadou-Anderjaska V., and Braga M.F. Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro. Neuroscience 159 (2009) 380-389
3. Aroniadou-Anderjaska V., Qashu F., and Braga M.F. Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders. Amino Acids 32 (2007) 305-315
4. Aroniadou-Anderjaska V., Fritsch B., Qashu F., and Braga M.F. Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy. Epilepsy Res 78 (2008) 102-116
5. Avoli M. Do interictal discharges promote or control seizures? Experimental evidence from an in vitro model of epileptiform discharge. Epilepsia 42 (2001) 2-4
6. Baille V., Clarke P.G., Brochier G., Dorandeu F., Verna J.M., Four E., et al. Soman-induced convulsions: the neuropathology revisited. Toxicology 215 (2005) 1-24
7. Bajgar J., Sevelova L., Krejcova G., Fusek J., Vachek J., Kassa J., et al. Biochemical and behavioral effects of soman vapors in low concentrations. Inhal Toxicol 16 (2004) 497-507
8. Bajgar J. Complex view on poisoning with nerve agents and organophosphates. Acta Medica (Hradec Kralove) 48 (2005) 3-21
9. Barbarosie M., and Avoli M. CA3-driven hippocampal-entorhinal loop controls rather than sustains in vitro limbic seizures. J Neurosci 17 (1997) 9308-9314
10. Barthold C.L., and Schier J.G. Organic phosphorus compounds-nerve agents. Crit Care Clin 21 (2005) 673-689
11. Baze W.B. Soman-induced morphological changes: an overview in the nonhuman primate. J Appl Toxicol 13 (1993) 173-177
12. Benini R., D'Antuono M., Pralong E., and Avoli M. Involvement of amygdala networks in epileptiform synchronization in vitro. Neuroscience 120 (2003) 75-84
13. Bettler B., Boulter J., Hermans-Borgmeyer I., O'Shea-Greenfield A., Deneris E.S., Moll C., et al. Cloning of a novel glutamate receptor subunit GluR5: expression in the nervous system during development. Neuron 5 (1990) 583-595
14. Braga M.F., Aroniadou-Anderjaska V., Xie J., and Li H. Bidirectional modulation of GABA release by presynaptic glutamate receptor 5 kainate receptors in the basolateral amygdala. J Neurosci 23 (2003) 442-452
15. Braga M.F., Aroniadou-Anderjaska V., and Li H. The physiological role of kainate receptors in the amygdala. Mol Neurobiol 30 (2004) 127-141
16. Brown M.A., and Brix K.A. Review of health consequences from high, intermediate, and low-level exposure to organophosphorus nerve agents. J Appl Toxicol 6 (1998) 393-408
17. Cendes F., Andermann F., Gloor P., Evans A., Jones-Gotman M., Watson C., et al. MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy. Neurology 43 (1993) 719-725
18. Cole A.E., and Nicoll R.A. Characterization of a slow cholinergic postsynaptic potential recorded in vitro from rat hippocampal pyramidal cells. J Physiol (Lond) 352 (1984) 173-188
19. Dewar S., Passaro E., Fried I., and Engel Jr. J. Intracranial electrode monitoring for seizure localization: indications, methods and the prevention of complications. J Neurosci Nurs 28 (1996) 280-289
20. Egorov A.V., Unsicker K., and von Bohlen und Halbach O. Muscarinic control of graded persistent activity in lateral amygdala neurons. Eur J Neurosci 24 (2006) 3183-3194
21. Engel J. Seizures and epilepsy (1989), F.A. Davis, Philadelphia
22. Feindel W., and Rasmussen T. Temporal lobectomy with amygdalectomy and minimal hippocampal resection: review of 100 cases. Can J Neurol Sci 18 (1991) 603-605
23. Fernández de Sevilla D., and Buño W. Presynaptic inhibition of Schaffer collateral synapses by stimulation of hippocampal cholinergic afferent fibres. Eur J Neurosci 17 (2003) 555-558
24. Fukudome Y., Ohno-Shosaku T., Matsui M., Omori Y., Fukaya M., Tsubokawa H., et al. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. Eur J Neurosci 19 (2004) 2682-2692
25. Goddard G.V. Development of epileptic seizures through brain stimulation at low intensity. Nature 214 (1967) 1020-1021
26. Goddard G.V., McIntyre D.C., and Leech C.K. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25 (1969) 295-330
27. Grasshoff C., Gillessen T., Thiermann H., Wagner E., and Szinicz L. The effect of acetylcholinesterase-inhibition on depolarization-induced GABA release from rat striatal slices. Toxicology 184 (2003) 149-156
28. Harrison P.K., Sheridan R.D., Green A.C., Scott I.R., and Tattersall J.E. A guinea pig hippocampal slice model of organophosphate-induced seizure activity. J Pharmacol Exp Ther 310 (2004) 678-686
29. Hayward I.J., Wall H.G., Jaax N.K., Wade J.V., Marlow D.D., and Nold J.B. Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. Neurol Sci 98 (1990) 99-106
30. Isokawa-Akesson M., Wilson C.L., and Babb T.L. Structurally stable burst and synchronized firing in human amygdala neurons: auto- and cross-correlation analyses in temporal lobe epilepsy. Epilepsy Res 1 (1987) 17-34
31. Jooma R., Yeh H.S., Privitera M.D., Rigrish D., and Gartner M. Seizure control and extent of mesial temporal resection. Acta Neurochir (Wien) 133 (1995) 44-49
32. Joosen M.J., Jousma E., van den Boom T.M., Kuijpers W.C., Smit A.B., Lucassen P.J., et al. Long-term cognitive deficits accompanied by reduced neurogenesis after soman poisoning. NeuroToxicology 30 (2009) 72-80
33. Kadar T., Shapira S., Cohen G., Sahar R., Alkalay D., and Raveh L. Sarin-induced neuropathology in rats. Hum Exp Toxicol 14 (1995) 252-259
34. Kairiss E.W., Racine R.J., and Smith G.K. The development of the interictal spike during kindling in the rat. Brain Res 322 (1984) 101-110
35. Kassa J., Koupilova M., Herink J., and Vachek J. The long-term influence of low-level sarin exposure on behavioral and neurophysiological functions in rats. Acta Medica (Hradec Kralove) 44 (2001) 21-27
36. Lallement G., Carpentier P., Collet A., Pernot-Marino I., Baubichon D., Sentenac-Roumanou H., et al. Involvement of glutamatergic system of amygdala in generalized seizures induced by soman: comparison with the hippocampus. CR Acad Sci III 313 (1991) 421-426
37. Lallement G., Carpentier P., Collet A., Pernot-Marino I., Baubichon D., and Blanchet G. Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res 563 (1991) 234-240
38. Lallement G., Denoyer M., Collet A., Pernot-Marino I., Baubichon D., Monmaur P., et al. Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures: influence of septal cholinoceptive cells. Neurosci Lett 139 (1992) 104-107
39. Lallement G., Dorandeu F., Filliat P., Carpentier P., Baille V., and Blanchet G. Medical management of organophosphate-induced seizures. J Physiol (Paris) 92 (1998) 369-373
40. Layish I., Krivoy A., Rotman E., Finkelstein A., Tashma Z., and Yehezkelli Y. Pharmacologic prophylaxis against nerve agent poisoning. Isr Med Assoc J 7 (2005) 182-187
41. Li H., Chen A., Xing G., Wei M.L., and Rogawski M.A. Kainate receptor-mediated heterosynaptic facilitation in the amygdala. Nat Neurosci 4 (2001) 612-620
42. López-Muñoz F., Alamo C., Guerra J.A., and García-García P. The development of neurotoxic agents as chemical weapons during the National Socialist period in Germany. Rev Neurol 47 (2008) 99-106
43. Madison D.V., Lancaster B., and Nicoll R.A. Voltage clamp analysis of cholinergic action in the hippocampus. J Neurosci 7 (1987) 733-741
44. McDonough Jr. J.H., Smith R.F., and Smith C.D. Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition. Toxicol Teratol 8 (1986) 179-187
45. McDonough Jr. J.H., Dochterman W., Smith C.D., and Shih T.-M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 15 (1995) 123-132
46. McDonough Jr. J.H., and Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 21 (1997) 559-579
47. McDonough Jr. J.H., Zoeffel L.D., McMonagle J., Copeland T.L., Smith C.D., and Shih T.M. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 38 (2000) 1-14
48. McIntyre D.C., and Racine R.J. Kindling mechanisms: current progress on an experimental epilepsy model. Prog Neurobiol 27 (1986) 1-12
49. Mohapel P., Dufresne C., Kelly M.E., and McIntyre D.C. Differential sensitivity of various temporal lobe structures in the rat to kindling and status epilepticus induction. Epilepsy Res 23 (1996) 179-187
50. Morimoto K., Fahnestock M., and Racine R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73 (2004) 1-60
51. Morita H., Yanagisawa N., Nakajima T., Shimizu M., Hirabayashi H., Okudera H., et al. Sarin poisoning in Matsumoto, Japan. Lancet 346 (1995) 260-261
52. Myhrer T., Andersen J.M., Nguyen N.H., and Aas P. Soman-induced convulsions in rats terminated with pharmacological agents after 45 min: neuropathology and cognitive performance. Neurotoxicology 26 (2005) 39-48
53. Myhrer T., Enger S., and Aas P. Efficacy of immediate and subsequent therapies against soman-induced seizures and lethality in rats. Basic Clin Pharmacol Toxicol 98 (2006) 184-191
54. Pitkänen A., Tuunanen J., Kalviainen R., Partanen K., and Salmenpera T. Amygdala damage in experimental and human temporal lobe epilepsy. Epilepsy Res 32 (1998) 233-253
55. Quesney L.F. Clinical and EEG features of complex partial seizures of temporal lobe origin. Epilepsia 27 (1986) S27-S45
56. Sah P., Faber E.S., Lopez De Armentia M., and Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 83 (2003) 803-834
57. 2+-dependent PKC. J Neurophysiol 98 (2007) 952-965
58. Santos M.D., Pereira E.F., Aracava Y., Castro N.G., Fawcett W.P., Randall W.R., et al. Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors. J Pharmacol Exp Ther 304 (2003) 254-265
59. Saukkonen A., Kalviainen R., Partanen K., Vainio P., Riekkinen P., and Pitkänen A. Do seizures cause neuronal damage? An MRI study in newly diagnosed and chronic epilepsy. Neuroreport 6 (1994) 219-223
60. Schecter W.P. Cholinergic symptoms due to nerve agent attack: a strategy for management. Anesthesiol Clin North America 22 (2004) 579-590
61. Shih T.M., and McDonough Jr. J.H. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol Biochem Behav 64 (1999) 147-153
62. Shih T., Duniho S.M., and McDonough J.H. Control of nerve agent induced seizures is critical for neuroprotection and survival. Toxicol Applied Pharm 188 (2003) 69-80
63. Smolders I., Bortolotto Z.A., Clarke V.R., Warre R., Khan G.M., O'Neill M.J., et al. Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizures. Nat Neurosci 5 (2002) 796-804
64. Solberg Y., and Belkin M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. TiPS 18 (1997) 183-185
65. Wade J.V., Samson F.E., Nelson S.R., and Pazdernik T.L. Changes in extracellular amino acids during soman- and kainic acid-induced seizures. J Neurochem 49 (1987) 645-650
66. Washburn M.S., and Moises H.C. Muscarinic responses of rat basolateral amygdaloid neurons recorded in vitro. J Physiol 449 (1992) 121-154
67. White L.E., and Price J.L. The functional anatomy of limbic status epilepticus in the rat. II. The effects of focal deactivation. J Neurosci 13 (1993) 4810-4830
68. Wieser H.G. Mesial temporal lobe epilepsy versus amygdalar epilepsy: late seizure recurrence after initially successful amygdalotomy and regained seizure control following hippocampectomy. Epileptic Disord 2 (2000) 141-152
69. Womble M.D., and Moises H.C. Muscarinic inhibition of M-current and a potassium leak conductance in neurones of the rat basolateral amygdala. J Physiol 457 (1992) 93-114
70. Yajeya J., De La Fuente A., Criado J.M., Bajo V., Sánchez-Riolobos A., and Heredia M. Muscarinic agonist carbachol depresses excitatory synaptic transmission in the rat basolateral amygdala in vitro. Synapse 38 (2000) 151-160